TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Cognitive performance on measures of attention and processing speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Advancement of the maxilla (SNA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intermaxillary changes (ANB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: calcification sum score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: time taken to give birth
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: discomfort with IOL
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: experience of subsequent contractions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cardiovascular death, myocardial infarction or stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Erythrocyte transketolase activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of anosmia after SAH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual analog scale impact score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: cumulative fluid loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum creatinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: net fluid loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to breastfeeding withholding recommendations
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: AFB smear conversion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Average percentage reduction in the size of gland
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average time taken for closure of sinuses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Periprocedural ischemic events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of kidney function loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Accuracy of interpretation of line graphs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clarity rating of line graphs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: NYHA functional class improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Median URTI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median number of days with URTI symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abnormal pH test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reflux parameters (% total time and % upright time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: 1-year cardiovascular events
Endpoint domain: Mortality/survival
Primary endpoint: coronary plaque progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diastolic function (E/e')
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: N-terminal pro-brain-type natriuretic peptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Average time suffering from acute respiratory distress syndrome (ARDS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean pathological lung lesion scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Frequency of depressive disorders
Endpoint domain: Adverse events/effects
Primary endpoint: percentage reduction in sensitivity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival rates within 1 month of the injury
Endpoint domain: Mortality/survival
Primary endpoint: P/Cr levels >/=0.2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: P/Cr levels >/=1.0
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Overall tolerance of the preparation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: visual field area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Engagement in shared decision-making (SDM)
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Use of formal SDM tools
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Awareness of sex and race-based differences in perceptions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: serum lubricin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of high spinal block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: get-up-and-go test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WOMAC disability score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to surgical intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total efficacy in treating EOLP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypercarbia incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Walking Time (WT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perception of smile beauty
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: HIV knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Condom-use skills
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: FACT-Fatigue subscale score improvements
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: gain in productive time
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: reduction in caregiver time
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Expression levels of TGFbeta1, TbetaRI, TbetaRII and Smad 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lipid absorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 60-month recall rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention rates for experimental groups
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical performance of low-shrinkage composites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of the mWellcare intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost-effectiveness of the mWellcare intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: sFas levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceleration in colon filling at 6 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Colonic transit at 24 and 48 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Increased stool consistency over 8 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Recovery of platelet function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean IPA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Average time for IPA to decline from 30% to 10%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of RUI forms returned incomplete or inaccurate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean systolic ambulatory 24-h BP change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Albuminuria control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Development of post-ERCP pancreatitis (PEP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: CYP3A activity alteration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: erythromycin exposure (AUC∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of major health conditions or hospitalizations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of dependent living
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Clinical delayed gastric emptying
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Plasma levels of melatonin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved ability to cope with pulmonary medication
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Fewer reported symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative reduction in serum PAB values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulmonary Artery Systolic Pressure (PAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pulmonary Artery Diastolic Pressure (PAD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pulmonary Artery Wedge Pressure (PAD-PAWP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: complete cessation of drainage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to cessation of drainage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to EUS evidence of fistula inactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight loss at 24 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Jamar Hand Grip Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in polydrug use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wound contamination frequency
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of participants who completed a FIT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants who completed any colorectal cancer screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of syllables stuttered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: typical stuttering severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: long-term benefit of spinal manipulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heat exchange level among body zones
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone mineral content stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 12-week 7-day point-prevalence abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postdose proteinuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: abuse liability-related subjective effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: psychomotor impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participation in leisure activities
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Satisfaction rates from life as a whole
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: odor discrimination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal metabolic activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve within the first 360 min after injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary free cortisol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Success rate of LPs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: facial aesthetics
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of ciliated cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in the number of lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: First acute exacerbation reported as a serious adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: First confirmed/suspected acute exacerbation reported as a serious adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of S. mutans and S. sobrinus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: SF-36 bodily pain scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Lequesne index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Enjoyment of SP interaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Value of SP interaction to overall education
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Performance on SP checklist
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in endothelium-dependent vasodilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: IUD expulsion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of treatment received due to adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in overall oral health status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: skin perfusion over the ischial tuberosity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: postoperative wound drainage volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in soluble intercellular adhesion molecule-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in morning peak expiratory flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Global tolerance to the procedure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: increase in delta power in prefrontal regions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: magnitude of symptomatic improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of systemic drug-related adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of systemic adverse events of special interest (AESIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of ocular drug-related adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Average mean percent change from baseline of inflammatory acne count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Patients’ satisfaction to acne severity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Quality of life (DLQI score)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Amplitude of the pupil reaction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Baseline pupil radius
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MLS BAER wave latencies and interpeak intervals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Marked improvement in depression state
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in SDS and HRSD scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative cognitive decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Frequency of anginal pain attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Blood pressure (BP) lowering
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Median EBL difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Median BCVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient preference for PK vs DSAEK
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Daily minutes of moderate‐to‐vigorous physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body weight decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sleep disturbance score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Altmetric scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mendeley reads
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Twitter impressions
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: TG increase from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 4-h TG levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: total and incremental area under the curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: MSNA during dynamic handgrip exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: tCO2 levels during dynamic handgrip exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference in peak workload
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood phenylalanine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Carers' positive comments
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total antisperm antibody reversing ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sperm motility and viability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: balance and gait outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PPT score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: trunk rotations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Engagement patterns of weight-tracker users
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Avoidance of repeat biopsies
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Diagnostic accuracy of PCA3 and %fPSA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: morbidity or complications of EVLT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: delivery of care
Endpoint domain: Resource use
Endpoint subdomain: Delivery of care
Primary endpoint: outcomes of care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of PMS symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: motor development
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Radiographic evidence of gross glenoid loosening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of dentin tubules occluded
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: A1C levels below 7%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Seizure occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Hypertension knowledge assessment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Satisfaction with intervention materials
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mood self-ratings
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Avoidance of VTE events
Endpoint domain: Mortality/survival
Primary endpoint: DI-S score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensitivity and specificity of the Hum Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diagnostic accuracy in assessing new onset unilateral CHL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DAS28 score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes